| TURİZMİN YEREL HALKIN YAŞAM KALİTESİ ÜZERİNDEKİ ETKİLERİ: MUĞLA-AKYAKA ÖRNEĞİ K Eser, N Çelik, O Yıldız Ekonomi Bilimleri Dergisi 10 (2), 60-73, 2018 | 15 | 2018 |
| Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study K Eser, AH Önder, E Sezer, T Çil, A İnal, B Öztürk, V Erçolak, BB Duman, ... BMC cancer 22 (1), 516, 2022 | 13 | 2022 |
| Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience A Bahçeci, S Paydaş, N Ak, F Ferhatoğlu, PM Saip, G Seydaoğlu, M Bilici, ... Cancer investigation 39 (6-7), 473-481, 2021 | 10 | 2021 |
| Meme kanserli kadınların cerrahi girişim sonrası yaşadıkları üst ekstremite sorunlarının yaşam kalitesine etkisi S Randa, GA Uğraş, K Eser Mersin Üniversitesi Sağlık Bilimleri Dergisi 12 (2), 170-181, 2019 | 4 | 2019 |
| Eritrosit Dağılım Genişliği (RDW): Metastatik Kolorektal Kanserde Prognoz Belirleyici Olarak Kullanımı K Eser, E Sezer, V Erçolak Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp …, 2019 | 3 | 2019 |
| Evaluation of biosimilar trastuzumab MYL-1401O in HER2-positive breast cancer. K Eser, E Sezer, V Erçolak, A İnal The American Journal of Managed Care 29 (2), e36-e42, 2023 | 2 | 2023 |
| Importance of Prognostic Nutritional Index in Patients with Metastatic Breast Cancer Treated with Trastuzumab Emtansine. T Koseci, G Bulut, S Ata, E Bayram, T Cil, K Eser Eurasian Journal of Medical Investigation 6 (4), 2022 | 1 | 2022 |
| Adrenal insidentaloma’lı hastalarda klinik, biyokimyasal ve radyolojik retrospektif analiz ZE Eser, R Gen, K Eser, K Sezer, E Akbay Mersin Üniversitesi Sağlık Bilimleri Dergisi 15 (2), 382-392, 2022 | 1 | 2022 |
| Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients K ESER, AH ÖNDER, E SEZER, T ÇİL, ALİ İNAL, B ÖZTÜRK, ... | 1 | 2021 |
| The clinical impact of incidental sellar uptake on F-18 FDG PET/CT ZP Koç, PÖ Kara, E Sezer, K Eser, A Özgür International Journal of Endocrine Oncology 6 (2), IJE15, 2019 | 1 | 2019 |
| Malignant Peripheral Nerve Sheath Tumor Staging on PET-CT Imaging in a Patient with Neurofibromatosis Type I PO Kara, ZP Koc, E Sezer, K Eser, V Ercolak Int J Radiol Radiat Ther 3 (4), 00070, 2017 | 1 | 2017 |
| Clinical, Biochemical, and Radiological Retrospective Analysis in Patients with Adrenal Incidentaloma–A Secondary Publication ZE Eser, R Gen, K Eser, K Sezer, E Akbay Proceedings of Anticancer Research 8 (1), 129-139, 2024 | | 2024 |
| Hastane kaynaklı ishallerde Clostridioides (Clostridium) difficile araştırılması. E Kaya, C Öztürk, ST Ülger, H Kaya, SA Tek Mersin Üniversitesi sağlık Bilimleri Dergisi 16 (3), 2023 | | 2023 |
| Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions ZP Koç, PÖ Kara, K Eser, H Sayar, B Güney Molecular Oncologic Imaging 2 (3), 52-55, 2022 | | 2022 |
| Erişkin Dönemin Nadir Görülen Beyin Tümörü: Medulloblastom Tanılı 28 Hastanın Demografik Özellikleri T Köşeci, S Ata, M Seyyar, P Olgun, E Bayram, K Eser, ZA Taş Journal of Cukurova Anesthesia and Surgical Sciences 5 (2), 235-240, 2022 | | 2022 |
| The F-18 FDG PET/CT evaluation of the metastatic adrenal lesions of the non-lung cancer tumors compared with pathology results ZP Koç, PP Özcan, E Sezer, K Eser, T Kara Egyptian Journal of Radiology and Nuclear Medicine 53 (1), 16, 2022 | | 2022 |
| Investigation of Regorafenib Efficacy in Patients with Metastatic Colorectal Carcinoma in Relation to the Delivered Dose Intensity/Body Surface Area K ESER, E SEZER, V ERÇOLAK, A İNAL, A ATAc, H BASIR, ... Journal of oncological sciences 8 (1), 34-42, 2022 | | 2022 |
| Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel T Köşeci, P Olgun, S Ata, E Bayram, MA Sungur, K Eser, BB Duman, T Çil Medical Science and Discovery 8 (12), 730-734, 2021 | | 2021 |
| Evaluation of biosimilar trastuzumab MYL-1401O in HER2-positive early-stage and metastatic breast cancer in real-life data K Eser, E Sezer, V Erçolak, A İnal | | 2021 |
| The Effect of Tumor Sideness and Mutational Status on First Line Treatment Response and Survival in The Patients with Metastatic Colorectal Cancer. K Eser, E Sezer, B Ozturk, AH Onder, V Ercolak, Z Oruc, A Inal UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2020 | | 2020 |
